Research & KnowledgeEvent: September 1, 2026
Corazon published a post in the TAVR coverage series examining the debate over CMS’s proposed approach to CED and its implications for quality oversight, registry participation, and future indications.
Published
Signal category
Research & Knowledge
Quote
“In the latest post in our TAVR coverage series, Dr. Harrington Steven examines the debate over CMS’s proposed approach to CED”
— Corazon team
Company
Corazon
Service line experts for program development in heart, vascular, neuro, ortho, spine, and surgical specialties.
- Industry
- Hospitals and Health Care
- Location
- Pittsburgh, US
- Company size
- 95 employees
Corazon is the national leader in program development for the Heart, Vascular, Neuroscience, Spine, Orthopedic, and Surgical specialties, offering services in Consulting, Recruitment, Interim Management, and Accreditation for health systems, hospitals, and ASCs. OUR MISSION: Our goal is to make a positive impact on healthcare delivery and patient care. 412-364-8200 corazon@corazoninc.com www.corazoninc.com
Founded 2001